Suppr超能文献

8 个华南家系黏多糖贮积症 IVA 的突变分析及致病性鉴定

Mutation analysis and pathogenicity identification of Mucopolysaccharidosis type IVA in 8 south China families.

机构信息

Department of Medical Genetics, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China.

Department of Internal Medicine, The Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, China.

出版信息

Gene. 2019 Feb 20;686:261-269. doi: 10.1016/j.gene.2018.11.051. Epub 2018 Nov 17.

Abstract

BACKGROUND

Mucopolysaccharidosis type IVA (MPS IVA) is a rare autosomal recessive lysosomal storage disorder caused by GALNS gene mutation. The aim of our study is to detect pathogenic variants for patients suspected of MPS IVA and set the base for subsequent prenatal diagnosis and preimplantation genetic diagnosis.

METHODS

In our study, 9 MPS IVA patients from south China families were investigated. Urine glycosaminoglycans (GAG) screening was used as an initial method. For patients with abnormal result, all 14 exons and intron-exon junctions of the GALNS gene were sequenced after amplification from genomic DNA. The pathogenicity of novel mutations were analyzed with molecular genetics, bioinformatics and structure modeling in light of clinical manifestations and biochemical results.

RESULTS

Among 12 mutations detected, direct sequencing found 3 novel mutations (c.686A>C, p.Y229S; c.1498G>T, p.G500C; c.278T>C, p.I93T). The pathogenicity of these novel mutations was illustrated by correlating clinical symptoms with pedigree analysis and bioinformatics analysis.

CONCLUSION

The detection and variant analysis are essential for accurate diagnosis of MPS IVA patients. Our results enrich GALNS gene mutation spectrum of Chinese population. This information has important clinical value for molecular diagnosis and genetic counseling of patients with this disease.

摘要

背景

黏多糖贮积症 IVA 型(MPS IVA)是一种罕见的常染色体隐性溶酶体贮积症,由 GALNS 基因突变引起。我们研究的目的是检测疑似 MPS IVA 患者的致病变异,并为后续的产前诊断和植入前遗传学诊断奠定基础。

方法

本研究对来自华南地区的 9 个 MPS IVA 家系患者进行了调查。尿糖胺聚糖(GAG)筛选作为初始方法。对于结果异常的患者,在扩增基因组 DNA 后,对 GALNS 基因的 14 个外显子和内含子-外显子接头进行测序。根据临床表现和生化结果,结合分子遗传学、生物信息学和结构建模分析新突变的致病性。

结果

在检测到的 12 个突变中,直接测序发现了 3 个新突变(c.686A>C,p.Y229S;c.1498G>T,p.G500C;c.278T>C,p.I93T)。通过将临床症状与家系分析和生物信息学分析相关联,说明了这些新突变的致病性。

结论

对 MPS IVA 患者进行检测和变异分析对于准确诊断至关重要。我们的研究结果丰富了中国人群 GALNS 基因突变谱。这些信息对于该疾病患者的分子诊断和遗传咨询具有重要的临床价值。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验